GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bayer BAYN.DE · EUR

Health Care · Pharmaceuticals · XETRA · 🇩🇪 Germany

DAXEuro Stoxx 50

Compare

56.62

+1.87%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Revenue

€45.58bn

FY2016FY2025

Net income

−€3.62bn

FY2016FY2025

Free cash flow

€2.08bn

FY2016FY2025

Shareholders' equity

€25.95bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue€45.58bn€46.61bn€47.64bn€50.74bn€44.08bn€41.40bn€43.55bn€36.74bn€35.02bn€34.94bn
Gross profit€26.98bn€25.34bn€27.89bn€30.87bn€27.27bn€22.26bn€25.93bn€21.36bn€23.63bn€23.19bn
Research and development€5.77bn€6.21bn€5.37bn€6.57bn€5.41bn€7.13bn€5.30bn€5.11bn€4.50bn€4.41bn
Operating income€6.95bn€4.48bn€8.41bn€8.24bn€7.93bn€12.0m€5.21bn€2.65bn€5.89bn€5.70bn
Net income−€3.62bn−€2.55bn−€2.94bn€4.15bn€1.00bn−€10.49bn€4.09bn€1.70bn€7.34bn€4.53bn
Diluted earnings per share-3.68-2.60-2.994.221.02-10.684.161.828.275.25

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets€110.61bn€110.85bn€116.26bn€124.88bn€120.24bn€117.05bn€126.26bn€126.28bn€75.09bn€82.24bn
Cash and short-term investments€7.86bn€8.09bn€10.59bn€10.15bn€7.74bn€11.88bn€5.40bn€4.34bn€9.10bn€5.42bn
Total liabilities€84.54bn€78.81bn€83.18bn€85.95bn€87.07bn€86.35bn€78.74bn€80.14bn€38.23bn€50.34bn
Debt€37.44bn€40.70bn€42.87bn€41.32bn€39.53bn€41.56bn€38.88bn€40.67bn€13.21bn€18.26bn
Shareholders' equity€25.95bn€31.91bn€32.93bn€38.77bn€33.02bn€30.52bn€47.34bn€45.98bn€36.80bn€30.33bn
Shares outstanding982m982m982m982m982m982m982m933m887m863m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations€4.57bn€7.37bn€5.12bn€7.09bn€5.09bn€4.90bn€8.21bn€7.92bn€8.13bn€9.09bn
Capital spending−€2.49bn−€2.78bn−€2.75bn−€2.95bn−€2.61bn−€2.42bn−€2.65bn−€2.59bn−€2.37bn−€2.58bn
Free cash flow€2.08bn€4.59bn€2.37bn€4.14bn€2.48bn€2.48bn€5.56bn€5.32bn€5.77bn€6.51bn
Dividends paid−€127.0m−€131.0m−€2.38bn−€1.99bn−€1.99bn−€2.77bn−€2.62bn−€2.41bn−€2.36bn−€2.13bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue€10.87bn€13.40bn€11.44bn€9.66bn€10.74bn€13.74bn€11.73bn€9.97bn
Gross profit€6.33bn€8.17bn€6.94bn€5.35bn€6.38bn€8.11bn€6.01bn€4.88bn
Operating income€827.0m€3.11bn€1.70bn€561.0m€1.58bn€3.07bn€478.0m−€3.71bn
Net income€219.0m€2.76bn−€3.76bn−€963.0m−€199.0m€1.30bn−€335.0m−€4.18bn
Diluted earnings per share0.222.81-3.82-0.98-0.201.32-0.34-4.26
Cash from operations€690.0m−€1.91bn€3.69bn€1.69bn€1.06bn−€1.01bn€5.00bn€2.11bn
Capital spending−€660.0m−€411.0m−€798.0m−€836.0m−€465.0m−€388.0m−€1.10bn−€605.0m
Free cash flow€30.0m−€2.32bn€2.89bn€849.0m€593.0m−€1.40bn€3.90bn€1.51bn
Total assets€107.28bn€107.94bn€110.61bn€104.21bn€105.24bn€109.18bn€110.85bn€106.95bn
Cash and short-term investments€5.08bn€6.66bn€7.86bn€7.24bn€5.50bn€5.38bn€8.09bn€6.34bn
Debt—€8.20bn€37.46bn€39.64bn€38.43bn€39.38bn€40.74bn€41.16bn
Shareholders' equity€29.58bn€28.84bn€25.95bn€29.58bn€30.37bn€32.45bn€31.91bn€30.56bn

Financial ratios

Data as of 18 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin59.2%54.4%58.5%60.8%61.9%53.8%
Operating margin15.3%9.6%17.7%16.2%18.0%0.0%
Net margin-7.9%-5.5%-6.2%8.2%2.3%-25.4%
Return on equity-14.0%-8.0%-8.9%10.7%3.0%-34.4%
Return on assets-3.3%-2.3%-2.5%3.3%0.8%-9.0%
Free cash flow yield14.9%21.4%16.6%21.2%16.2%15.4%
Revenue growth-2.2%-2.2%-6.1%15.1%6.5%-4.9%
Earnings growth41.8%-13.2%-170.9%315.0%-109.5%-356.5%
Current ratio1.00x1.19x1.27x1.08x1.11x0.97x
Debt to equity1.40x1.25x1.34x1.05x1.17x1.33x
Equity ratio23.5%28.8%28.3%31.0%27.5%26.1%
Interest coverage4.04x2.29x4.85x4.92x6.44x0.01x
R&D as a share of sales12.7%13.3%11.3%13.0%12.3%17.2%
Buybacks as a share of market value0.0%0.0%0.0%-0.0%0.0%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-3.5%1.9%-0.1%
Operating income-5.5%257.0%1.0%
Net income—-19.2%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin56.8%58.3%58.2%59.2%
Operating margin12.4%14.7%13.1%13.1%
Net margin-6.7%-2.6%-5.2%1.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-10.0-7.4-11.211.446.2-4.517.533.312.418.6
Price to sales0.80.40.70.91.11.11.61.52.62.4

Dividends and splits

Per share, in the currency the company pays

Paid for 36 years. Last went ex-dividend on 27 Apr 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.110.110.112.402.002.002.802.80
  • 1-to-1 reverse split · 21 Sept 2009
  • 1-to-1 reverse split · 15 Jun 1998
  • 10-for-1 split · 3 Jun 1996

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.